Shandong Sino-Agri United Biotechnology Co., Ltd. Class A

As of June 30, 2026, Shandong Sino-Agri United Biotechnology Co., Ltd. Class A carries a market capitalization of 1.73B, placing it among publicly traded companies globally. Its enterprise value stands at 2.69B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Shandong Sino-Agri United Biotechnology Co., Ltd. Class A has 142.48M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Shandong Sino-Agri United Biotechnology Co., Ltd. Class A maintains a current ratio of 0.59, meaning it holds 0.6x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, Shandong Sino-Agri United Biotechnology Co., Ltd. Class A recorded an income tax benefit of -23.19M rather than an expense, typically from losses, carryforwards, or the release of a tax provision.

As of the close on October 23, 2026, Shandong Sino-Agri United Biotechnology Co., Ltd. Class A's stock has declined approximately 24.16% over the past 52 weeks. The 50-day moving average sits at 14.08, while the 200-day moving average is 15.51.

As of June 30, 2026, Shandong Sino-Agri United Biotechnology Co., Ltd. Class A holds 304.83M in cash and equivalents against 1.26B in total debt, resulting in a net debt position of 588.83M. Total book value stands at 1.18B, with working capital of -1.06B providing operational flexibility.

These figures cover the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, Shandong Sino-Agri United Biotechnology Co., Ltd. Class A paid dividends of 0.11 per share.

Shandong Sino-Agri United Biotechnology Co., Ltd. Class A's most recent stock split took place on June 22, 2022 with a 10:13 split ratio.